Respirerx Pharmaceuticals Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2021 | - | Sales 2022 | - | Capitalization | 289K 397K |
---|---|---|---|---|---|
Net income 2021 | -3M -4.12M | Net income 2022 | -2M -2.75M | EV / Sales 2021 | - |
Net Debt 2021 | 2.08M 2.85M | Net Debt 2022 | 2.71M 3.72M | EV / Sales 2022 | - |
P/E ratio 2021 |
-0.29
x | P/E ratio 2022 |
-0.06
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 93.37% |
Managers | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 13-03-21 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 13-03-21 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 14-10-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 13-03-21 |
Director/Board Member | - | 23-03-21 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 13-03-21 |
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |